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Abstract
Objectives
The placental transfer of nutrients is influenced by maternal metabolic state, placenta func-
tion and fetal demands. Human in vivo studies of this interplay are scarce and challenging.
We aimed to establish a method to study placental nutrient transfer in humans. Focusing on
glucose, we tested a hypothesis that maternal glucose concentrations and uteroplacental
arterio-venous difference (reflecting maternal supply) determines the fetal venous-arterial
glucose difference (reflecting fetal consumption).
Methods
Cross-sectional in vivo study of 40 healthy women with uncomplicated term pregnancies un-
dergoing planned caesarean section. Glucose and insulin were measured in plasma from
maternal and fetal sides of the placenta, at the incoming (radial artery and umbilical vein)
and outgoing vessels (uterine vein and umbilical artery).
Results
There were significant mean (SD) uteroplacental arterio-venous 0.29 (0.23) mmol/L and
fetal venous-arterial 0.38 (0.31) mmol/L glucose differences. The transplacental maternal-
fetal glucose gradient was 1.22 (0.42) mmol/L. The maternal arterial glucose concentration
was correlated to the fetal venous glucose concentration (r = 0.86, p<0.001), but not to the
fetal venous-arterial glucose difference. The uteroplacental arterio-venous glucose differ-
ence was neither correlated to the level of glucose in the umbilical vein, nor fetal venous-
arterial glucose difference. The maternal-fetal gradient was correlated to fetal venous-arteri-
al glucose difference (r = 0.8, p<0.001) and the glucose concentration in the umbilical artery
(r = −0.45, p = 0.004). Glucose and insulin concentrations were correlated in the mother
(r = 0.52, p = 0.001), but not significantly in the fetus. We found no significant correlation be-
tween maternal and fetal insulin values.
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Conclusions
We did not find a relation between indicators of maternal glucose supply and the fetal venous-
arterial glucose difference. Our findings indicate that the maternal-fetal glucose gradient is
significantly influenced by the fetal venous-arterial difference and not merely dependent on
maternal glucose concentration or the arterio-venous difference on the maternal side of
the placenta.
Introduction
Fetal development comprises the entire intrauterine process of differentiation, growth and
maturation between conception and birth. The conditions under which a fetus develops are
recognised to have major impact on the future health of the newborn child [1]. The develop-
mental environment of the fetus is dependent on maternal nutritional and metabolic state [2,
3] and on the placental function as most nutrients must be transported from the maternal cir-
culation across the placenta to the fetus. The placenta also secretes hormones and growth fac-
tors that change maternal metabolism profoundly [4]. Therefore, placenta governs to a large
extent the environment in which the fetus develops and grows.
Increasing maternal fasting glucose levels are associated with higher birthweight, neonatal
fat percentage and risk of large babies. [2, 3, 5–7]. Glucose is the main source of energy for the
fetus and the placenta. Under normal conditions the fetus has no significant gluconeogenesis
and is dependent on glucose transfer from the mother [8]. Glucose is transferred over the pla-
centa by facilitated diffusion, via glucose transport proteins belonging to the GLUT-family [9].
Human studies have demonstrated a robust correlation between the maternal and fetal glucose
levels [10]. The Pedersen hypothesis states that high maternal glucose levels lead to high fetal
glucose and insulin levels [11]. The current clinical understanding is that the consequence is in-
creased glucose consumption and fetal growth. However experimental data indicate that fetal
glucose consumption is affected by other factors than maternal glucose supply alone. The net
transfer of glucose over the placenta is thought to be influenced by the maternal-fetal glucose
concentration gradient, surface area, transporter density and glucose metabolism of the placen-
ta as well as blood flow [9, 12–15]. The maternal-fetal gradient can be increased by higher level
of glucose on the maternal side which is clinically what we monitor and if necessary regulate.
The maternal-fetal gradient will however also increase with lower glucose levels on the fetal
side of the placenta. [12, 13]. Fundamental studies on pregnant ewes and in vitro perfusion
studies indicate that fetal glucose uptake is influenced by fetal glucose levels as well as maternal
glucose levels [12, 13, 16]. However, extrapolation to human in vivo condition is hampered by
the considerable anatomical and functional differences in the fetoplacental unit among mam-
malian species. Interestingly, studies of GLUT transporter densities showed different responses
to hyperglycaemia depending on whether the exposure was in vivo or in vitro [15]. This obser-
vation probably reflects that in vivo there are multiple factors influencing transporter expres-
sion and activity. Human in vivo studies of placental physiology are scarce as the placenta is
largely unavailable during pregnancy. Glucose and insulin concentrations in maternal and fetal
circulations are reported in smaller human studies, of which several were performed during the
stress of vaginal delivery [17–20].
Increased insight into the interplay between maternal supply, placental transfer and fetal de-
mand and consumption of nutrients in humans requires a model that provides data from all
these three compartment simultaneously. We believe part of this information can be gained by
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measuring levels of nutrients in the arteries and veins on both the maternal and fetal side of the
placenta simultaneously. Calculating the arterio-venous differences and the transplacental gra-
dient gives an opportunity to study how placental uptake and transfer of nutrients are altered
by maternal and fetal factors. Thus, our first aim was to establish the 4-vessel procedure for col-
lection of these arterial and venous blood samples from both sides of the placenta. The second
aim was to describe placental glucose transfer per litre blood passing by determining the utero-
placental arterio-venous (a-v) difference (reflecting the uteroplacental uptake), the fetal ve-
nous-arterial (v-a) difference (reflecting the fetal consumption) and the maternal-fetal gradient
(reflecting the transplacental transfer). We tested the hypothesis that the fetal v-a glucose dif-
ference is mainly determined by maternal glucose concentration and the uteroplacental a-v
glucose difference.
Materials and Methods
Ethics Statement
All participants signed a written informed consent. The study was approved by the relevant
board at our institution and the Regional Committee for Medical and Health Research Ethics,
Southern Norway 2419/2011.
Design and study population
A cross-sectional in vivo study consisting of 40 women with uncomplicated pregnancies under-
going planned caesarean section. Healthy, non-smoking women with singleton pregnancy
were included at Oslo University Hospital from October 2012 until April 2013.
Exclusion criteria were pre-existing morbidity, medication and pregnancy complications.
Gestational diabetes not requiring insulin treatment was not an exclusion criterion, based on
the rationale that there are no clear metabolic distinction between this group and those defined
not to have diabetes. Contractions prior to scheduled caesarean section lead to exclusion.
Data collection
Clinical data was collected at inclusion. The women were weighed on an impedance scale
(Tanita Body composition Analyser, Tokyo, Japan) at the day of delivery. First trimester BMI
was calculated based on the first recorded weight, of which 14 were self reported. Gestational
weight gain was calculated as the difference between weight at delivery and first trimester.
Caesarean section was performed in spinal anaesthesia (bupivacaine10 mg, fentanyl 20 μg).
The women fasted for at least 8 hours and did not receive intravenous glucose infusions. When
the uterine vein was exposed immediately before uterine incision blood samples were obtained
from a uterine vein on the anterolateral surface of the uterus, intentionally on the same side as
placenta. Simultaneously, blood was drawn form the radial artery and from a venous catheter
in the medial cubital vein or dorsal vein network of the hand. Blood samples were obtained
from the umbilical artery and vein immediately after cord clamping, but before delivery of
the placenta.
We used Safety Blood Collection set with Luer Adapter coupled on sterile syringes. Blood
samples were immediately transferred to ethylenediaminetetraacetic acid vacutainers (Greiner
bio-one, Kremsmunster, Austria), and kept on ice. They were centrifuged at 6°C, 2500 G for 20
minutes, before the supernatants were carefully removed, leaving 0,5 ml to assure platelet free
plasma, and stored at- 80°C.
Assays were performed by accredited laboratories according to standard laboratory methods
(Department of Medical Biochemistry, Oslo University Hospital, Rikshospitalet) during three
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following days. Glucose was measured by the hexokinase/glucose-6-phosphate dehydrogenase
enzymatic in vitro test (Roche, Mannheim, Germany). Insulin was analysed using the electro-
chemiluminescence immunoassay (Roche, Mannheim, Germany).
We assumed similar blood composition in the radial and the uterine artery. Thus, the utero-
placental a-v difference was calculated as the difference in glucose concentration between the
radial artery and the uterine vein. The fetal v-a glucose difference was calculated as the differ-
ence in glucose concentration between the umbilical vein (transporting blood from the placen-
ta to the fetus) and the umbilical artery (transporting blood from the fetus to the placenta). The
maternal-fetal glucose gradient was calculated as the difference in glucose between the mater-
nal radial artery and the umbilical artery.
Statistics
Descriptive data were reported as mean values with standard deviations (SD) or numbers with
percentages as appropriate. Glucose values were reported as mean values (SD). Comparisons
between concentrations of glucose in maternal and fetal vessels, respectively, were performed
by paired t-tests. Due to skewed distributions, insulin concentrations were reported as median
values with inter quartile ranges (IQR) and comparisons of related samples were performed by
Wilcoxon sign rank test. Correlations were reported as Pearson’s correlation coefficient if one
variable was normally distributed, whereas Spearman’s rank correlation coefficient was used in
the case of correlation between two skewed variables. A two-sided p-value< 0.05 was consid-
ered significant. All analyses were performed using Statistical Package for the Social Sciences,
Version 18.0 (SPSS Inc., Hong Kong).
Results
Characteristics of the participants are shown in Table 1. The glucose concentrations including
the concentration differences derived from them and their interpretation are shown in Fig. 1.
Placenta extracted 6% of the glucose available per litre maternal blood passing, calculated by
dividing the uteroplacental a-v glucose difference (0.29mmol/L) by the concentration in the ra-
dial artery (4.71mmol/L). By similar calculation the fetus consumed approximately 10% of glu-
cose per litre blood flowing in the fetal-placental circulation.
Maternal arterial and fetal venous concentrations of glucose were highly correlated (r = 0.86,
p<0.001). Maternal arterial glucose concentration was not significantly correlated to the fetal
v-a glucose difference (r = 0.3, p = 0.07). The uteroplacental a-v glucose difference was neither
correlated to the level of glucose in the umbilical vein, nor the fetal v-a glucose difference. The
maternal-fetal gradient was highly correlated with the fetal v-a difference (r = 0.8, p<0.001).
The maternal-fetal glucose gradient was also correlated with the glucose concentration in the
umbilical artery (r = -0.38, p = 0.017), whereas it was no correlation was found with the glucose
concentration in the umbilical vein. Similarly, the fetal v-a glucose difference was only correlat-
ed with the glucose concentration in the umbilical artery (r = -0.45, p = 0.004), but not with the
glucose concentration in the umbilical vein (Fig. 2 and S1 Table).
The glucose concentration in the umbilical vein was not related to birthweight or placental
weight, whereas correlation between the fetal v-a glucose difference and birthweight reached
significance, (r = 0.32, p = 0.049) (S1 Table).
Insulin concentrations are given in Table 2. We found no correlation between maternal and
fetal insulin values (rho = −0.1, p = 0.57). Maternal and fetal concentrations of insulin were not
statistically different. On the maternal side glucose and insulin concentrations were correlated
(r = 0.52, p = 0.001). On the fetal side, however, no such correlation was found (r = 0.12,
p = 0.48), but fetal insulin was correlated to the fetal v-a glucose difference (r = 0.43, p = 0.007).
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Fetal insulin was also correlated to placental weight (r = 0.46, p = 0.003) and birthweight (r = 0.58,
p<0.001) (S1 Table).
Discussion
The 4-vessel sampling method was successfully implemented in our maternity ward and we ob-
tained both arterial and venous samples from 40 mother-infant pairs.
Glucose
We found the expected arterio-venous differences in glucose concentrations on both sides of
the placenta, reflecting uteroplacental uptake of glucose on the maternal side and fetal uptake
of glucose on the fetal side. The concentrations were higher on the maternal than on the fetal
side, demonstrating a transplacental maternal-fetal gradient also in the fasting state.
The maternal-fetal gradient is recognized as the main driving force behind the facilitated
diffusion of glucose over the placenta. Even though we found the expected strong correlation
between maternal and umbilical glucose concentrations we found no significant association be-
tween maternal concentrations and fetal v-a difference. Moreover there was no correlation be-
tween the uteroplacental a-v difference and the fetal v-a difference. The maternal-fetal gradient
and the fetal v-a difference were strongly correlated. Taken together, these findings suggest that
fetal v-a glucose difference is not just affected by incoming glucose. This notion is supported by
Table 1. Maternal and neonatal characteristics.
n % Mean (SD) Range
Mothers 40
Age (years) 36.3 (3.2) 30–43
Para 0 10 25
Para 1 20 50
Para>1 10 25
BMI ﬁrst trimester 24.0 (3.7) 17.6–38.6
BMI at delivery 29.2 (4.2) 22.4–41.2
Weight gain (kg) 14.1 (4.0) 7.3–23.8
Married or partnership 40 100
Higher education (15 years) 36 92.3
Smoking during pregnancya 0 0
Gestational diabetesb 1 2.5
In vitro fertilization 4 10
Infants 40
Gestational age (weeks) 39.4 (0.5) 38.0–41.1
Birthweight (g) 3571 (527) 2680–4955
Placenta weight (g)c 656 (160) 341–1115
Birth/placental weight ratio 5.6 (1.0) 4.2–8.1
Sex (boys) 19 47.5
Apgar 5 min 40 9.5 (0.7) 7–10
aOne woman stopped smoking when pregnancy was conﬁrmed in ﬁrst trimester
bDeﬁned after WHO-criteria. Plasma glucose 7.8mmol/L 2h after an oral glucose tolerance test of 75g glucose
cUntrimmed, without blood clots
doi:10.1371/journal.pone.0117084.t001
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data from experimental studies which demonstrate that fetal glucose v-a difference is not sim-
ply related to the maternal concentration, but separately regulated by the fetal concentration of
glucose [12]. The maternal-fetal gradient may be increased either by elevated glucose on the
maternal side or by lower concentrations on the fetal arterial side [12, 13]. The latter concentra-
tion is largely determined by the fetal glucose consumption, demonstrating a way by which the
fetus itself may regulate the transplacental glucose transport. The lack of correlation between
the uteroplacental a-v difference and the fetal v-a difference might be due to the fact that a sig-
nificant fraction of the glucose is metabolized by the placenta and the uterus [13, 18]. It has
been demonstrated that placental glucose uptake and metabolism is related to fetal arterial glu-
cose concentration [21]. Our results add to the complexity of nutrient transfer from the mother
to the fetus. The assumption that controlling maternal blood glucose ensures control of fetal
glucose uptake does not take into account the metabolism and consumption of nutrients that
take place in the placenta. This is reflected in the clinical observation that even diabetic mothers
with optimal blood glucose control have increased risk of delivering large for gestational
age infants.
Insulin
In this study glucose and insulin concentrations were not correlated in the fetal circulation, as
opposed to in the maternal circulation. The physiological relation between insulin and glucose
in the fetus is different from the mother. In the mother nutrients pass through the gut and the
gastrointestinal hormones mediates additional stimulation of the pancreatic secretion of insu-
lin in response to the meal. The fetus, on the other hand, has ongoing intravenous supply of
Fig 1. Glucose concentrations and gradients (mmol/L).Glucose concentrations were measured in the arteries and veins on the maternal and fetal side of
the placenta. *p<0.001, paired t-test. Calculated parameters and their interpretations: Uteroplacental a-v difference = [Radial artery]-[Uterine vein] Reflects
uteroplacental uptake per litre blood passing. Fetal v-a difference = [Umbilical vein]-[Umbilical artery]. Reflects fetal consumption per litre blood passing.
Maternal-fetal gradient = [Radial artery]-[Umbilical artery]. Reflects transplacental transfer per litre blood passing.
doi:10.1371/journal.pone.0117084.g001
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Fig 2. Correlations betweenmaternal and fetal glucose concentrations and gradients. A & B. The maternal arterial glucose concentration was
significantly correlated to the glucose concentration in the umbilical vein, r = 0.86, p<0.001, but not to the fetal v-a glucose difference, r = 0.3, p = 0.07.
C & D. The fetal v-a glucose difference was significantly correlated to the maternal-fetal glucose gradient r = 0.8, p<0.001 and the glucose concentration in
the umbilical artery r = −0.38, p = 0.017.
doi:10.1371/journal.pone.0117084.g002
Table 2. Glucose and insulin concentrations.
Vessel Mean glucose mmol/L (SD) Median insulin pmol/L (IQR)
Radial artery 4.71 (0.48) 56.0 (30.3–83.2)
Antecubital vein 4.56 (0.45) 49.6 (26.4–67.2)
Uterine vein 4.41 (0.45) 38.5 (23.9–55.7)
Umbilical vein 3.87 (0.41) 62.4 (36.9–92.0)
Umbilical artery 3.48 (0.45) 58.5 (34.8–85.9)
doi:10.1371/journal.pone.0117084.t002
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glucose, thus bypassing the gut response [22]. The pancreatic response to a rise in blood glu-
cose is different in fetal life. In experimental ovine studies Hay et al. concluded that basal insu-
lin secretion has little effect on fetal glucose metabolism, but that glucose stimulated insulin
secretion does occur, increases over gestation and is enhanced by pulsatile hyperglycaemia
[12]. As our mothers were in a fasting state it is possible that the glucose stimulated insulin se-
cretion played a limited role at the time of sampling.
Comparison with other studies
Most previous studies of glucose and insulin concentrations in the human uteroplacental unit
have been conducted during vaginal delivery, making comparison to our study difficult because
of the non-fasting state and the physiological stress. These original studies have however dem-
onstrated a consistent correlation between the maternal glucose concentration and glucose con-
centration in the umbilical vein, and also explored the relationship between fetal glucose and
insulin [23, 24]. Several studies have demonstrated an inconsistent fetal insulin response to glu-
cose. This has led to the notion that insulin is primarily a growth promoting factor in the fetus
[10, 23, 25]. In our study fetal insulin was indeed positively correlated to both birthweight and
placental weight. In experimental studies fetal insulin infusions led to reduced fetal glucose con-
centration, but increased fetal glucose v-a difference (mg min-1kg-1) [26]. Interestingly, fetal in-
sulin was also associated with the fetal v-a glucose difference in our material.
We have found three other human studies of fetal v-a glucose difference comparable to our
setting, which is fasting women delivered by elective caesarean section near term. Only one
study comprising 8 women had complete data on glucose and insulin in arterial and venous
vessels on both the maternal and the fetal side of the placenta [20]. One study found a fetal v-a
glucose difference comparable to our study, but lacked data from the maternal arterial circula-
tion [17]. Despite lower maternal arterial glucose levels than in our study, the two other studies
reported larger fetal v-a difference, uteroplacental a-v difference and maternal fetal gradient
[20, 27] (S1 Table). These two studies had relatively lower glucose concentration in the umbili-
cal artery which contributed in creating the larger fetal v-a difference and maternal-fetal gradi-
ent. There is no consistent difference in insulin levels which can explain these differences. The
birthweight was similar between the studies, but there was a difference in the placental efficien-
cy measured as birth/placental weight ratio.
Measurements of concentrations and blood flow (ml/min) on both sides of the placenta
makes it possible to quantify the actual mass (g) of nutrients delivered to, taken up by and trans-
ported over the uteroplacental unit, as well as the mass consumed by the fetus. Zamudio et al.
included these flow measurements on the maternal and fetal side of the placenta [27]. They
found a significant relation between fetal glucose in the umbilical vein (mmol min-1kg-1) and
fetal glucose v-a difference (μmol min-1kg-1), both multiplied with umbilical blood flow and
normalized to birthweight. They did not report if fetal v-a difference was correlated with utero-
placental glucose a-v difference at the maternal side of the placenta or if it was correlated with
glucose concentrations in the umbilical artery.
Strengths and limitations
The current study is limited by lack of maternal and fetal blood flow data, and thus compares
glucose delivered per liter blood passing the placenta. In particular, flow measurements in the
uteroplacental circulation is methodologically demanding and published data so far show a
large divergence that may include considerable variations beyond the biological ones [28–30].
Furthermore, the flow assessment should be performed as close as possible in time to the blood
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sampling. This is logistically highly requiring in a busy hospital setting, but never the less nec-
essary in future studies.
Our study included women scheduled for elective caesarean section and hence our sample
has higher age and parity than the average pregnant population. The fasting state limits inter-
pretation of the results. The cross-sectional design near term gives no opportunity to evaluate
longitudinal changes or nutritional transport at earlier gestational ages.
The strength of this study is the acquisition of human in vivo blood samples from 40 indi-
viduals on both sides of the uteroplacental unit, under standardized conditions. No complica-
tions were observed neither when sampling from the radial artery nor from the uterine vein.
The samples were handled by strict procedures.
Conclusion
In conclusion, our method provides novel data on human placental glucose transfer in vivo
and may be applied to any nutrients or substance of interest. We did not find support for the
hypothesis that fetal v-a glucose difference, as a reflection of fetal consumption, is directly relat-
ed to the supply of glucose from the maternal circulation. Our findings indicate that the trans-
placental transfer, measured as the maternal-fetal gradient, is significantly influenced by the
fetal v-a glucose difference and not merely dependent on maternal glucose concentration or
the glucose a-v difference on maternal side.
Supporting Information
S1 Table. Correlations between glucose concentrations and gradients, insulin, placental
weight and birthweight.
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S2 Table. Maternal and fetal glucose concentrations and gradients. Comparisons between
four studies.
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